Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 345 of 1,261
  1. US 11001863

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted May 11, 2021 · Expires May 6, 2041

    granted
  2. US 11001845

    Nucleic acid molecules targeting superoxide dismutase 1 (SOD1)

    Phio Pharmaceuticals Corp. · Granted May 11, 2021 · Expires May 6, 2041

    granted
  3. US 11001783

    Synthesis and use of ω-hydroxylated polyunsaturated fatty acids

    The Regents of the University of California · Granted May 11, 2021 · Expires May 6, 2041

    granted
  4. US 11001844

    CRISPR/Cas-related methods and compositions for treating herpes simplex virus

    Editas Medicine, Inc. · Granted May 11, 2021 · Expires May 6, 2041

    granted
  5. US 11001631

    Clec9A binding agents

    Orionis Biosciences, Inc · Granted May 11, 2021 · Expires May 6, 2041

    granted
  6. US 11001613

    TFPI inhibitors and methods of use

    Takeda Pharmaceutical Company Limited · Granted May 11, 2021 · Expires May 6, 2041

    granted
  7. US 11001610

    Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof

    Apellis Pharmaceuticals, Inc. · Granted May 11, 2021 · Expires May 6, 2041

    granted
  8. US 11001618

    Overexpression of FOXC1 to treat corneal vascularization

    Northwestern University · Granted May 11, 2021 · Expires May 6, 2041

    granted
  9. US 11001603

    Modulators of 5′-nucleotidase, ecto and the use thereof

    Arcus Biosciences, Inc. · Granted May 11, 2021 · Expires May 6, 2041

    granted
  10. US 11001609

    Cell permeable cyclic peptide scaffolds

    The Regents of the University of California · Granted May 11, 2021 · Expires May 6, 2041

    granted
  11. US 11001592

    DNA polymerase IIIC inhibitors and use thereof

    Acurx Pharmaceuticals, Inc. · Granted May 11, 2021 · Expires May 6, 2041

    granted
  12. US 11001627

    Correctly folded etanercept in high purity and excellent yield

    Coherus BioSciences, Inc. · Granted May 11, 2021 · Expires May 6, 2041

    granted
  13. US 11000602

    Delivery of small interfering RNA and micro RNA through nanogels containing hydrophobic pseudo-peptides

    The Board of Regents of the University of Texas System · Granted May 11, 2021 · Expires May 6, 2041

    granted
  14. US 11001578

    N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors

    KalVista Pharmaceuticals Limited · Granted May 11, 2021 · Expires May 6, 2041

    granted
  15. US 11000711

    Compositions for forming films having a desired degree of obscuration and methods of making and using the same

    W.R. Grace & Co.-Conn. · Granted May 11, 2021 · Expires May 6, 2041

    granted
  16. US 11000599

    Peptidic self-assembly for nucleic acid delivery

    S. M. DISCOVERY GROUP INC. · Granted May 11, 2021 · Expires May 6, 2041

    granted
  17. US 11000595

    Modulators of PCSK9 expression

    Ionis Pharmaceuticals, Inc. · Granted May 11, 2021 · Expires May 6, 2041

    granted
  18. US 11000600

    Exon skipping oligomer conjugates for muscular dystrophy

    Sarepta Therapeutics, Inc. · Granted May 11, 2021 · Expires May 6, 2041

    granted
  19. US 11000593

    Cellular or viral membrane coated nanostructures and uses thereof

    The Regents of the University of California · Granted May 11, 2021 · Expires May 6, 2041

    granted
  20. US 11000588

    Etanercept formulations stabilized with sodium chloride

    Coherus BioSciences, Inc. · Granted May 11, 2021 · Expires May 6, 2041

    granted
  21. US 11000576

    Enzymes and methods for cleaving n-glycans from glycoproteins

    The Regents of the University of California · Granted May 11, 2021 · Expires May 6, 2041

    granted
  22. US 11000561

    Adeno-associated virus purification methods

    Takeda Pharmaceutical Company Limited · Granted May 11, 2021 · Expires May 6, 2041

    granted
  23. US 11000568

    Means and methods for treating copper-related diseases

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 11, 2021 · Expires May 6, 2041

    granted
  24. US 11000517

    Dosage and formulation

    Almirall, S.A. · Granted May 11, 2021 · Expires May 6, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.